ATTRACT - Clinical Research Group
@attract-crg.bsky.social
Personalized targeted #glioblastoma therapies by ex vivo drug screening
ATTRACT is an Austrian 🇦🇹 Clinical Research Group dedicated to improving therapy for glioblastoma, the most aggressive brain tumor in adults 🧠💊
https://tinyurl.com/attract-crg
ATTRACT is an Austrian 🇦🇹 Clinical Research Group dedicated to improving therapy for glioblastoma, the most aggressive brain tumor in adults 🧠💊
https://tinyurl.com/attract-crg
🚀 Another milestone for expanding nationwide access to precision care for #glioblastoma! 🇦🇹
The first patient included in our biobanking program at Klinik Donaustadt has been randomized 🎉
👏 Thanks to the local team, @lbg.ac.at & all partners.
#NeuroOncology #ClinicalTrials #btsm
The first patient included in our biobanking program at Klinik Donaustadt has been randomized 🎉
👏 Thanks to the local team, @lbg.ac.at & all partners.
#NeuroOncology #ClinicalTrials #btsm
November 26, 2025 at 7:27 PM
🚀 Another milestone for expanding nationwide access to precision care for #glioblastoma! 🇦🇹
The first patient included in our biobanking program at Klinik Donaustadt has been randomized 🎉
👏 Thanks to the local team, @lbg.ac.at & all partners.
#NeuroOncology #ClinicalTrials #btsm
The first patient included in our biobanking program at Klinik Donaustadt has been randomized 🎉
👏 Thanks to the local team, @lbg.ac.at & all partners.
#NeuroOncology #ClinicalTrials #btsm
🧠 Bringing #PrecisionOncology to life!
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
October 18, 2025 at 10:48 AM
🧠 Bringing #PrecisionOncology to life!
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy.
👏 Thanks to @lbg.ac.at & all partners in 🇦🇹!
#NeuroOncology #ClinicalTrials #btsm
🎯 How can we make #PrecisionMedicine real for #glioblastoma?
🧠 The #ATTRACT trial tests 28 drugs on patient-derived cells & uses a molecular tumor board for #personalized therapy recommendation.
📚 Read our protocol paper in #NeuroOncology Advances: doi.org/10.1093/noaj...
📲 Follow us for updates!
🧠 The #ATTRACT trial tests 28 drugs on patient-derived cells & uses a molecular tumor board for #personalized therapy recommendation.
📚 Read our protocol paper in #NeuroOncology Advances: doi.org/10.1093/noaj...
📲 Follow us for updates!
Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)
AbstractBackground. Novel approaches to guide personalized treatment in glioblastoma are urgently needed. Given the poor predictive value of genetic biomar
doi.org
September 8, 2025 at 1:12 PM
🎯 How can we make #PrecisionMedicine real for #glioblastoma?
🧠 The #ATTRACT trial tests 28 drugs on patient-derived cells & uses a molecular tumor board for #personalized therapy recommendation.
📚 Read our protocol paper in #NeuroOncology Advances: doi.org/10.1093/noaj...
📲 Follow us for updates!
🧠 The #ATTRACT trial tests 28 drugs on patient-derived cells & uses a molecular tumor board for #personalized therapy recommendation.
📚 Read our protocol paper in #NeuroOncology Advances: doi.org/10.1093/noaj...
📲 Follow us for updates!
🚀 #ATTRACT wächst!
⛔️ #KlinischeStudien sollten nicht nur auf wenige Zentren beschränkt sein. Deshalb erweitern wir unser #Biobanking, um Patient:innen mit #Glioblastom in ganz #Österreich 🇦🇹 Zugang zu ATTRACT zu ermöglichen.
🎉 Meilenstein: 1. Patient in Wiener Neustadt eingeschlossen!
⛔️ #KlinischeStudien sollten nicht nur auf wenige Zentren beschränkt sein. Deshalb erweitern wir unser #Biobanking, um Patient:innen mit #Glioblastom in ganz #Österreich 🇦🇹 Zugang zu ATTRACT zu ermöglichen.
🎉 Meilenstein: 1. Patient in Wiener Neustadt eingeschlossen!
August 12, 2025 at 4:17 PM
🚀 #ATTRACT wächst!
⛔️ #KlinischeStudien sollten nicht nur auf wenige Zentren beschränkt sein. Deshalb erweitern wir unser #Biobanking, um Patient:innen mit #Glioblastom in ganz #Österreich 🇦🇹 Zugang zu ATTRACT zu ermöglichen.
🎉 Meilenstein: 1. Patient in Wiener Neustadt eingeschlossen!
⛔️ #KlinischeStudien sollten nicht nur auf wenige Zentren beschränkt sein. Deshalb erweitern wir unser #Biobanking, um Patient:innen mit #Glioblastom in ganz #Österreich 🇦🇹 Zugang zu ATTRACT zu ermöglichen.
🎉 Meilenstein: 1. Patient in Wiener Neustadt eingeschlossen!
🚀 #ATTRACT is growing!
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
August 12, 2025 at 4:15 PM
🚀 #ATTRACT is growing!
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT.
🎉 Milestone: 1st patient enrolled in Wiener Neustadt!
#NeuroOncology #PrecisionMedicine #CancerResearch
🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy.
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
Die KFG ATTRACT
YouTube video by Ludwig Boltzmann Gesellschaft
youtu.be
July 30, 2025 at 4:51 PM
🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy.
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀
youtu.be/NfxxMZ_xmF4
🚀 We’re launching the BlueSky presence of #ATTRACT - a 🇦🇹 Clinical Research Group investigating ex-vivo drug screening 💊 for personalized #glioblastoma treatment, funded by @lbg.ac.at with @meduniwien.ac.at as lead institution.
➡️ Follow us for further insights!
🧠 #GlioblastomaAwarenessDay #NeuroOnc
➡️ Follow us for further insights!
🧠 #GlioblastomaAwarenessDay #NeuroOnc
July 16, 2025 at 4:08 PM
🚀 We’re launching the BlueSky presence of #ATTRACT - a 🇦🇹 Clinical Research Group investigating ex-vivo drug screening 💊 for personalized #glioblastoma treatment, funded by @lbg.ac.at with @meduniwien.ac.at as lead institution.
➡️ Follow us for further insights!
🧠 #GlioblastomaAwarenessDay #NeuroOnc
➡️ Follow us for further insights!
🧠 #GlioblastomaAwarenessDay #NeuroOnc